128 related articles for article (PubMed ID: 2832630)
1. Potency and receptors involved in coronary vasoconstriction caused by neuropeptide Y(NPY).
Aizawa Y; Satoh M; Aizawa M; Funazaki T; Niwano S; Miyajima S; Shibata A
Jpn Heart J; 1987 Nov; 28(6):891-8. PubMed ID: 2832630
[TBL] [Abstract][Full Text] [Related]
2. Coronary vasoconstrictive effects of neuropeptide Y and their modulation by the ATP-sensitive potassium channel in anesthetized dogs.
Tanaka E; Mori H; Chujo M; Yamakawa A; Mohammed MU; Shinozaki Y; Tobita K; Sekka T; Ito K; Nakazawa H
J Am Coll Cardiol; 1997 May; 29(6):1380-9. PubMed ID: 9137239
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y (NPY): a coronary vasoconstrictor and potentiator of catecholamine-induced coronary constriction.
Macho P; Pérez R; Huidobro-Toro JP; Domenech RJ
Eur J Pharmacol; 1989 Aug; 167(1):67-74. PubMed ID: 2776842
[TBL] [Abstract][Full Text] [Related]
4. Vasoconstrictor effect of neuropeptide Y (NPY) on canine coronary artery.
Aizawa Y; Murata M; Hayashi M; Funazaki T; Ito S; Shibata A
Jpn Circ J; 1985 Jun; 49(6):584-8. PubMed ID: 3839860
[TBL] [Abstract][Full Text] [Related]
5. Effect of nifedipine on neuropeptide Y-induced coronary vasoconstriction in anesthetized dogs.
Hayashi M; Aizawa Y; Satoh M; Suzuki K; Shibata A
Jpn Heart J; 1986 Mar; 27(2):251-7. PubMed ID: 3755186
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of the vasoconstrictor action of neuropeptide-Y by calcium-channel blockers.
Aizawa Y; Niwano S; Aizawa M; Tamura M; Shibata A
Angiology; 1989 Oct; 40(10):890-4. PubMed ID: 2802259
[TBL] [Abstract][Full Text] [Related]
7. Intense sympathetic stimulation releases neuropeptide Y but fails to evoke sustained coronary vasoconstriction in dogs.
Otani N; Yang T; Levy MN
Circ Res; 1993 Apr; 72(4):816-26. PubMed ID: 8443869
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
Lundberg JM; Modin A
Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
[TBL] [Abstract][Full Text] [Related]
9. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
[TBL] [Abstract][Full Text] [Related]
10. Haemodynamic effects of intracoronary neuropeptide Y in dogs: resistance to alpha adrenergic blockade.
Stack RK; Patterson RE
Cardiovasc Res; 1991 Sep; 25(9):757-63. PubMed ID: 1666019
[TBL] [Abstract][Full Text] [Related]
11. Transmural regulation of myocardial perfusion by neuropeptide Y.
Gutterman DD; Morgan DA
Basic Res Cardiol; 1995; 90(4):348-55. PubMed ID: 8534260
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of nicorandil on sympathetic coronary vasoconstriction.
Chujo M; Mori H; Tanaka E; Nakazawa H; Okino H
Cardiovasc Res; 1994 Jun; 28(6):917-22. PubMed ID: 7923299
[TBL] [Abstract][Full Text] [Related]
13. Adenosine receptor blockade with 8-p-sulfophenyltheophylline aggravates coronary constriction.
Martin SE; Tidmore WC; Patterson RE
Am J Physiol; 1991 Jun; 260(6 Pt 2):H1753-9. PubMed ID: 2058714
[TBL] [Abstract][Full Text] [Related]
14. Interaction of neuropeptide Y and the sympathetic nervous system in vascular control in man.
Clarke J; Benjamin N; Larkin S; Webb D; Maseri A; Davies G
Circulation; 1991 Mar; 83(3):774-7. PubMed ID: 1999028
[TBL] [Abstract][Full Text] [Related]
15. Coronary constriction due to neuropeptide Y: alleviation with cyclooxygenase blockers.
Martin SE; Patterson RE
Am J Physiol; 1989 Sep; 257(3 Pt 2):H927-34. PubMed ID: 2506768
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide-Y. A peptide found in human coronary arteries constricts primarily small coronary arteries to produce myocardial ischemia in dogs.
Maturi MF; Greene R; Speir E; Burrus C; Dorsey LM; Markle DR; Maxwell M; Schmidt W; Goldstein SR; Patterson RE
J Clin Invest; 1989 Apr; 83(4):1217-24. PubMed ID: 2703530
[TBL] [Abstract][Full Text] [Related]
17. Effects of age and hyperlipidemia on rabbit coronary responses to neuropeptide Y and the interaction with norepinephrine.
Corr L; Burnstock G; Poole-Wilson P
Peptides; 1993; 14(2):359-64. PubMed ID: 8483814
[TBL] [Abstract][Full Text] [Related]
18. Modulation by neuropeptide Y of parasympathetic nerve-evoked nasal vasodilatation via Y2 prejunctional receptor.
Lacroix JS; Ulman LG; Potter EK
Br J Pharmacol; 1994 Oct; 113(2):479-84. PubMed ID: 7834199
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y is a vasoconstrictor of human coronary arteries.
Tseng CJ; Robertson D; Light RT; Atkinson JR; Robertson RM
Am J Med Sci; 1988 Jul; 296(1):11-6. PubMed ID: 3407677
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y potentiates contractile response to norepinephrine in skate coronary artery.
Bjenning C; Holmgren S; Farrell AP
Am J Physiol; 1993 Aug; 265(2 Pt 2):H661-5. PubMed ID: 8368368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
